PATENT CLAIM ANALYSIS

Application Number: 15864156
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["424", "190100"]

Abstract:
Provided are non-typeable  Haemophilus influenzae  vaccines useful for the treatment of chronic obstructive pulmonary disease and asthma in a patient. In certain aspects, the vaccine is a monobacterial vaccine. Bacterial strains for use in the vaccines of the present application are also provided.

Claim (Index 47):
The composition of  claim 40 , wherein the membrane fraction comprises an outer membrane protein fraction of isolate NTHi-164.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 86.0
- Lexical Diversity: 1.34286
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13059185', '12531402', '14316935', '11096850', '11573889']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7292855727035978
- 35 USC 102 Novelty (BERT): 0.6145393238423441
- Combined Prediction Score: 0.7178109478174726
- Mean Citation Score: 392.168242
- Max Citation Score: 666.25665
- Similarity Product: 449.4507827224732

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test